Innerer Wert von S&P & Nasdaq Kontaktieren

American Oriental Bioengineering, Inc. AOBI OTC

Other OTC • Healthcare • Biotechnology • CN • USD

SharesGrow Score
27/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

American Oriental Bioengineering, Inc. (AOBI) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Biotechnologie Branche. Der Hauptsitz des Unternehmens ist in Beijing, China. Der aktuelle CEO ist Shujun Liu.

AOBI hat IPO-Datum 2001-12-12, 3,719 Vollzeitbeschäftigte, gelistet an der Other OTC, eine Marktkapitalisierung von $88.00.

Über American Oriental Bioengineering, Inc.

American Oriental Bioengineering, Inc. engages in the development, manufacture, and commercialization of various pharmaceutical and healthcare products. The company primarily provides prescription pharmaceutical products, including Shuanghuanglian Lyophilized Injection Powder under the SHL brand for the treatment of flu symptoms, such as high fever, cough, and sore throat, as well as upper respiratory infections, mild pneumonia, bronchitis, and tonsillitis; and Cease Enuresis Soft Gel under the CE Gel brand to alleviate bedwetting. It also offers over-the-counter pharmaceutical products comprising Cease Enuresis Patch for the treatment of bedwetting and incontinence; Jinji Capsule for the treatment of endometritis, annexitis, and pelvic inflammations; Jinji Yimucao for the treatment of premenstrual syndrome (PMS) and other PMS and menopause-related symptoms; and Boke Nasal Spray for the treatment of sinus congestion from common cold, stuffy nose, chronic rhinitis, allergic rhinitis, and nasosinusitis. In addition, the company provides various nutraceutical products, such as soybean peptide based drinks, tablets, powder, and instant coffee. Further, it is involved in the wholesale and retail of pharmaceutical and nutraceutical products. The company sells its products directly and through distributors to hospitals, clinics, pharmacies, supermarkets, fitness centers, specialty nutraceutical stores, and other retail outlets in the People's Republic of China. American Oriental Bioengineering, Inc. is headquartered in Beijing, China.

📍 1 First Liangshuihe Avenue, Beijing 100176 📞 86 10 5982 2039
Unternehmensdetails
SektorGesundheitswesen
BrancheBiotechnologie
LandChina
BörseOther OTC
WährungUSD
IPO-Datum2001-12-12
CEOShujun Liu
Mitarbeiter3,719
Handelsinformationen
Aktueller Kurs$0.00
Marktkapitalisierung$88.00
52-Wochen-Spanne0.0005-0.0012
Beta0.01
ETFNein
ADRNein
Kontaktieren
🎓
SharesGrow Akademie
Lernen Sie inneren Wert zu berechnen und unterbewertete Aktien zu finden.
Wöchentliche Live-Sessions
Nachricht senden